Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.1.
Document Type
Article
Publication Date
5-20-2023
Publication Title
Journal of Clinical Oncology
Abstract
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis; as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline.
Volume
41
Issue
15
First Page
e42
Last Page
e50
Recommended Citation
Singh N, Jaiyesimi IA, Ismaila N, Leighl NB, Mamdani H, Phillips T, et al. Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO Living Guideline, Version 2023.1. J Clin Oncol. 2023 May 20:41(15):e42-e50. doi: 10.1200/JCO.23.00281. PMID: 37023367.
DOI
10.1200/JCO.23.00281
ISSN
1527-7755
PubMed ID
37023367